Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | yes | yes: 15 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 6, no: 0 | 
| NetGPI | no | yes: 0, no: 6 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 | 
| GO:0110165 | cellular anatomical entity | 1 | 5 | 
Related structures:
AlphaFold database: A4HUD1
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 44 | 48 | PF00656 | 0.478 | 
| CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.559 | 
| CLV_NRD_NRD_1 | 234 | 236 | PF00675 | 0.573 | 
| CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.554 | 
| CLV_PCSK_KEX2_1 | 234 | 236 | PF00082 | 0.573 | 
| CLV_PCSK_PC7_1 | 230 | 236 | PF00082 | 0.538 | 
| CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.662 | 
| CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.684 | 
| DEG_SCF_FBW7_1 | 62 | 69 | PF00400 | 0.482 | 
| DOC_CKS1_1 | 123 | 128 | PF01111 | 0.467 | 
| DOC_PP4_FxxP_1 | 123 | 126 | PF00568 | 0.480 | 
| DOC_USP7_MATH_1 | 161 | 165 | PF00917 | 0.426 | 
| DOC_USP7_MATH_1 | 214 | 218 | PF00917 | 0.684 | 
| DOC_USP7_MATH_1 | 39 | 43 | PF00917 | 0.405 | 
| DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.457 | 
| DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.485 | 
| DOC_WW_Pin1_4 | 212 | 217 | PF00397 | 0.701 | 
| DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.462 | 
| LIG_14-3-3_CanoR_1 | 131 | 135 | PF00244 | 0.475 | 
| LIG_14-3-3_CanoR_1 | 144 | 148 | PF00244 | 0.381 | 
| LIG_14-3-3_CanoR_1 | 183 | 190 | PF00244 | 0.567 | 
| LIG_14-3-3_CanoR_1 | 5 | 14 | PF00244 | 0.526 | 
| LIG_14-3-3_CanoR_1 | 57 | 63 | PF00244 | 0.406 | 
| LIG_FHA_1 | 107 | 113 | PF00498 | 0.507 | 
| LIG_FHA_1 | 15 | 21 | PF00498 | 0.672 | 
| LIG_FHA_1 | 185 | 191 | PF00498 | 0.455 | 
| LIG_FHA_1 | 200 | 206 | PF00498 | 0.436 | 
| LIG_FHA_1 | 57 | 63 | PF00498 | 0.406 | 
| LIG_FHA_2 | 218 | 224 | PF00498 | 0.712 | 
| LIG_LIR_Apic_2 | 121 | 126 | PF02991 | 0.468 | 
| LIG_LIR_Gen_1 | 220 | 226 | PF02991 | 0.725 | 
| LIG_LIR_Nem_3 | 146 | 151 | PF02991 | 0.422 | 
| LIG_LIR_Nem_3 | 90 | 96 | PF02991 | 0.408 | 
| LIG_PTAP_UEV_1 | 167 | 172 | PF05743 | 0.585 | 
| LIG_PTB_Apo_2 | 246 | 253 | PF02174 | 0.753 | 
| LIG_PTB_Phospho_1 | 246 | 252 | PF10480 | 0.753 | 
| LIG_SH2_CRK | 97 | 101 | PF00017 | 0.379 | 
| LIG_SH2_NCK_1 | 45 | 49 | PF00017 | 0.430 | 
| LIG_SH2_STAP1 | 222 | 226 | PF00017 | 0.683 | 
| LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.447 | 
| LIG_SH2_STAP1 | 97 | 101 | PF00017 | 0.392 | 
| LIG_SH3_2 | 126 | 131 | PF14604 | 0.481 | 
| LIG_SH3_3 | 123 | 129 | PF00018 | 0.464 | 
| LIG_SH3_3 | 165 | 171 | PF00018 | 0.574 | 
| LIG_SH3_3 | 33 | 39 | PF00018 | 0.472 | 
| LIG_SUMO_SIM_anti_2 | 17 | 24 | PF11976 | 0.551 | 
| LIG_SUMO_SIM_par_1 | 17 | 24 | PF11976 | 0.686 | 
| MOD_CDK_SPxxK_3 | 212 | 219 | PF00069 | 0.704 | 
| MOD_CK1_1 | 150 | 156 | PF00069 | 0.451 | 
| MOD_CK1_1 | 164 | 170 | PF00069 | 0.338 | 
| MOD_CK1_1 | 217 | 223 | PF00069 | 0.694 | 
| MOD_CK1_1 | 80 | 86 | PF00069 | 0.478 | 
| MOD_CK2_1 | 217 | 223 | PF00069 | 0.706 | 
| MOD_CK2_1 | 263 | 269 | PF00069 | 0.694 | 
| MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.684 | 
| MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.725 | 
| MOD_GlcNHglycan | 81 | 85 | PF01048 | 0.558 | 
| MOD_GSK3_1 | 143 | 150 | PF00069 | 0.446 | 
| MOD_GSK3_1 | 162 | 169 | PF00069 | 0.471 | 
| MOD_GSK3_1 | 184 | 191 | PF00069 | 0.498 | 
| MOD_GSK3_1 | 214 | 221 | PF00069 | 0.665 | 
| MOD_GSK3_1 | 259 | 266 | PF00069 | 0.683 | 
| MOD_GSK3_1 | 39 | 46 | PF00069 | 0.399 | 
| MOD_GSK3_1 | 58 | 65 | PF00069 | 0.358 | 
| MOD_GSK3_1 | 76 | 83 | PF00069 | 0.293 | 
| MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.624 | 
| MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.731 | 
| MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.590 | 
| MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.682 | 
| MOD_N-GLC_2 | 249 | 251 | PF02516 | 0.553 | 
| MOD_NEK2_1 | 104 | 109 | PF00069 | 0.418 | 
| MOD_NEK2_1 | 184 | 189 | PF00069 | 0.491 | 
| MOD_NEK2_1 | 20 | 25 | PF00069 | 0.617 | 
| MOD_NEK2_2 | 143 | 148 | PF00069 | 0.470 | 
| MOD_OFUCOSY | 155 | 160 | PF10250 | 0.647 | 
| MOD_PIKK_1 | 162 | 168 | PF00454 | 0.465 | 
| MOD_PKA_2 | 130 | 136 | PF00069 | 0.471 | 
| MOD_PKA_2 | 143 | 149 | PF00069 | 0.382 | 
| MOD_PKA_2 | 56 | 62 | PF00069 | 0.399 | 
| MOD_Plk_1 | 5 | 11 | PF00069 | 0.539 | 
| MOD_Plk_4 | 130 | 136 | PF00069 | 0.474 | 
| MOD_Plk_4 | 14 | 20 | PF00069 | 0.568 | 
| MOD_Plk_4 | 143 | 149 | PF00069 | 0.372 | 
| MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.460 | 
| MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.485 | 
| MOD_ProDKin_1 | 212 | 218 | PF00069 | 0.701 | 
| MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.464 | 
| MOD_SUMO_rev_2 | 150 | 156 | PF00179 | 0.355 | 
| MOD_SUMO_rev_2 | 257 | 266 | PF00179 | 0.672 | 
| TRG_ENDOCYTIC_2 | 222 | 225 | PF00928 | 0.784 | 
| TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.397 | 
| TRG_ER_diArg_1 | 233 | 235 | PF00400 | 0.779 | 
| TRG_NLS_MonoExtC_3 | 230 | 235 | PF00514 | 0.732 | 
| TRG_NLS_MonoExtN_4 | 230 | 235 | PF00514 | 0.732 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1HYT1 | Leptomonas seymouri | 54% | 87% | 
| A0A3S7WR08 | Leishmania donovani | 100% | 100% | 
| A4H604 | Leishmania braziliensis | 68% | 100% | 
| E9AN31 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% | 
| Q4QHJ5 | Leishmania major | 92% | 100% |